Trials / Completed
CompletedNCT00296803
PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic Syndrome
PROCLAIM: Pilot Study Examining Effects of Clopidogrel Compared to Placebo on Markers of Inflammation in Subjects With Metabolic Syndrome
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 216 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine the effects of clopidogrel compared to placebo on markers of inflammation in subjects with metabolic syndrome who are receiving background therapy including low dose aspirin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clopidogrel |
Timeline
- Start date
- 2005-11-01
- Completion
- 2006-08-01
- First posted
- 2006-02-27
- Last updated
- 2011-01-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00296803. Inclusion in this directory is not an endorsement.